COVID-19 taking financial toll on people in U.S. with diabetes
Unemployment and income loss caused by the pandemic are higher among those with diabetes than in the general U.S. population.
Real-world data show SGLT2 inhibitors for diabetes triple DKA risk
The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.
Cleaner data confirm severe COVID-19 link to diabetes, hypertension
Initial reports that tied more severe COVID-19 disease to diabetes or hypertension used confounded data, but more refined data show similar links...
Guidance addresses elders with diabetes during COVID-19
Two geriatricians from the Joslin Diabetes Center offer advice for navigating the challenges associated with helping these vulnerable adults...
Hyperglycemia predicts COVID-19 death even without diabetes
This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.
Delayed diagnoses seen in children during COVID-19
"Pediatricians on the frontline know what to expect with diabetes. Those children who would have come in late prior to the pandemic are now...
Captopril questioned for diabetes patients in COVID-19 setting
Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors...
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early...
ED visits for life-threatening conditions declined early in COVID-19 pandemic
Visits for MI, stroke, and hypoglycemic crisis dropped 10%-23% over the first 10 weeks.
Cost of preventable adult hospital stays topped $33 billion in 2017
Heart failure, diabetes, and COPD were the most expensive preventable conditions.